Novo Nordisk is investigating the potential of Ozempic, Wegovy’s active ingredient and two other drug candidates as treatments for alcohol-related liver disease.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Ozempic, Wegovy to be tested as alcohol-related liver disease therapies
